S.NO. Company/ University Head of Company Country/ Place Last Vaccine by
Company
Trials Date Expected
Date of
Result
Technology
Used for CoVID 19 Vaccine
Expected Roll Out
1. Altimmune Inc. Dr. Vipin Garg US NasoVax April 2020 (Expected) NA Intranasal
Adenovirus
Vector Vaccine
2. CanSino Biologics Yu Xuefeng China SARS-CoV spike protein 23/03/2020
Phase I
Single Used Bioreactor System
3. Clover
Biopharmaceuticals Inc,
GlaxoSmithKline plc &Dynavax Technologies Corp.
Pen Liang;
Emma
Natasha Walmsley and CEPI
China May 2020 NA Trimer tag Technology
4. CureVac AG Pierre
Kemula and CEPI
Germany April 2020 (expected) NA mRNA Based vaccine
5. Expres2ion
Biotechnologies ApS
Dr. Martin
Roland
Jensen
Denmark MERS and SARS January 2021 NA Insect Cell Expression
6. Generex Biotechnology;
Biology Institute of
Shandong Academy of
Sciences
S. Gail
Eckhardt and
Melinda
Foundation
China & US May 2020 NA Li-key Immune system
Activation
7. IbioInc; Beijing CC Pharming Ltd. Robert B. Kay China Approval waited for
clinical trials
NA FastPharming
Sytem (Plant
Produced)
8. Imperial College of
London
Robin
Shattock and CEPI
UK April 2020 (expected) NA Antibody therapy
S.NO. Company/ University Head of Company Country/ Place Last Vaccine by
Company
Trials Date Expected
Date of
Result
Technology
Used for CoVID 19 Vaccine
Expected Roll Out
9. Inovio Pharma; Beijing Advaccine Biotech. Co. Ltd; Genome Lifescience
Inc.
J. Joseph Kim and Funds By Bill Gates China & US MERS April 2020
(Human
trials
expected)
September 2020 DNA Vaccine
10. LinearxInc; Takis Biotech James Hayward New
York &
Italy
April 2020 (expected) NA Polymerase
Chain Reaction
11. Medicago Inc. Dr. Bruce Clark Canada SARS CoV 2 gene July 2020 (expected) NA Basic Antibodies response
12. Moderna Therapeutics
Inc.; Kaiser Permanente
Health Research Inc.;
NIAID
Bill  Gates and CEPI US Zika Vaccine, SARS 1 16/03/2020 (Human trial) NA mRNA based Vaccine
13. Novavax Inc. Staney C.
Erckand CEPI
US MERS May 2020 (expected) NA Nanoparticles vaccine
14. The Jenner Institute; University of Oxford Prof. Adrian
Hill
UK MERS 28/03/2020
(Phase I)
NA Adenovirus
Vector Encoding
15. Stermirna therapeutics
Co. Ltd.; Tongji University
Li Hangwen China April 2020 (expected) NA mRNA based vaccine
16. University of Queensland Peter Hoj and CEPI Australia May 2020 (expected) NA Protein subunit based
17. University of Saskatchewan Richard
Peter
Stoicheff
Canada NA NA Different strains of coronavirus
18. Vaxart Inc. Wouter W. Latour UK June 2020 (expected) NA Recombinant protein vaccine
S.NO. Company/ University Head of Company Country/ Place Last Vaccine by
Company
Trials Date Expected
Date of
Result
Technology
Used for CoVID 19 Vaccine
Expected Roll Out
19. Vaxil Bio Ltd. Ari S. Kellen Israel July 2020 (expected) NA Peptide vaccine based on bioinformatics
20. Walter Reed Army
Institute of Research and
US Army Medical
Research and
Development Command
Col. Deydre S. Teyhen US Ebola July 2020 (expected) NA MERS research
21. ZydusCadilla Pankaj Patel India NA NA rMeasles Virus vector based
22. Mayo Vaccine Research Group Dr. Gregory Poland China 25/03/2020 NA Based on
Peptide Subunit
23. University of Western Ontario Canada May 2020 (expected) NA Bioinformatics and genetic imaging
24. National School of Tropical Medicine Peter Hotez US SARS 1 May 2020 (expected) NA Development from SARS
25. Cambridge University Jonathan Henley UK Ebola Looking for Funds NA Antibodies induced enhancing
26. State Key Laboratory for
Emerging Infectious Diseases
Xiang Zhang Hong
Kong, China
H1N1 April 2020 NA Based on Flu Vaccine
27. BioNTech SE and Pfizer Inc. UgurSahin Germany Cancer related April 2020 (Expected) NA mRNA baaed
28. CytoDyn Inc. Nader Z.
Pourhassan
USA HIV April 2020 (Expected) NA Antibodies response based
29. Heat Biologics Inc. Jeffrey Wolf USA Immunotherapy April 2020 (Expected) NA Based on Flu Vaccine
S.NO. Company/ University Head of Company Country/ Place Last Vaccine by
Company
Trials Date Expected
Date of
Result
Technology
Used for CoVID 19 Vaccine
Expected Roll Out
30. Johnson & Johnson Alex Gorsky USA HIV September 2020 NA mRNA Based
31. Regeneron
Pharmaceuticals Inc
Leonard Schleifer USA Ebola May 2020 NA Peptide bond Based
32. Sanofi Paul Hudson France Rubella April 2020 (Expected) NA
33. India’s Serum Institute Cyrus
Poonawalla
India Swine Fly April 2020 (Expected) January 2021 Antibodies response Based
34. Bharat Biotech Dr. Krishna
Ella
India RotaVac April 2020 (Expected) December 2020 Nasal Vaccine
35. GeoVax and BravoVax Farshad
Guirakhkoo
US HIV NA NA
36. University of Pittsburgh Louis Falo US MERS 2 April 2020
Preclinical Trial
NA Based on SARS CoV 1 Vaccine
1. Remdesivir antiviral protease
inhibitor against coronaviruses
investigational Gilead, WHO, INSERM China, Japan
initially;
expanded to multiple countries in Europe and N.
America in Global Solidarity and Discovery
Trials
April (Chinese, Japanese trials) to mid2020
2. Hydroxychloroquine or Chloroquine antiparasitic and antirheumatic; generic made by many manufacturers malaria, rheumatoid arthritis, lupus (International) CEPI, WHO, INSERM Multiple sites in
China; Global
Solidarity and
Discovery Trials, Europe, international
April 2020 (Chinese trials); mid2020

3. Favipiravir antiviral against influenza influenza (China) Fujifilm China April 2020
4. Lopinavir/Ritonavir antiviral, immune suppression investigational combination; lopinavir/ritonavir approved CEPI, WHO, UK
Government,
Univ. of Oxford,
INSERM
Global Solidarity and Discovery Trials, multiple countries mid-2020
5. Sarilumab human monoclonal antibody against interleukin-6 receptor rheumatoid arthritis (USA, Europe) Regeneron-
Sanofi
Multiple countries Spring 2020
6. ASC-09 + Ritonavir antiviral combination not approved; ritonavir approved for HIV Ascletis Pharma Multiple sites in China Spring 2020
 

7. Tocilizumab human monoclonal antibody against interleukin-6 receptor immunosuppression, rheumatoid arthritis (USA, Europe) GenentechHoffmann-La
Roche
Multiple countries mid-2020
Categories: Vaccine